TRO and hepatocellular carcinoma: Although the applicability of KIAA1114 as a single biomarker to isolate TICs from multiple HCC subtypes offers unique advantages over other established TIC markers, it is crucial to validate its function by sorting KIAA1114high cells from clinical samples.